North American Scientific, Inc.

U.S. FDA clearance received for nTRAK patient positioning system

Published in Medical Imaging Business Week, August 4th, 2005

North American Scientific, Inc., (NASI) announced that its NOMOS Radiation Oncology division has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market nTRAK, its new stereotactic image guidance system used to position and monitor patients during radiation therapy treatments for head and neck cancers.

The new nTRAK system utilizes an optical camera and fiducial markers attached to a customized bite block to provide assurance that a patient is positioned reproducibly within required tolerances throughout a course of radiation therapy treatments. The company expects sales of nTRAK to begin in the fourth quarter of fiscal 2005.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Business Week

Source: Medical Imaging Business Week (2005-08-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry